- Home
- CYRX vs HRTX Comparison
CYRX vs HRTX Comparison
Compare CYRX & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYRX
- HRTX
- Stock Information
- Founded
- CYRX 1999
- HRTX 1983
- Country
- CYRX United States
- HRTX United States
- Employees
- CYRX N/A
- HRTX N/A
- Industry
- CYRX Biotechnology: Pharmaceutical Preparations
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- CYRX Health Care
- HRTX Health Care
- Exchange
- CYRX Nasdaq
- HRTX Nasdaq
- Market Cap
- CYRX 310.4M
- HRTX 270.7M
- IPO Year
- CYRX N/A
- HRTX 1987
- Fundamental
- Price
- CYRX $5.55
- HRTX $1.84
- Analyst Decision
- CYRX Strong Buy
- HRTX Strong Buy
- Analyst Count
- CYRX 7
- HRTX 3
- Target Price
- CYRX $11.29
- HRTX $5.67
- AVG Volume (30 Days)
- CYRX 559.3K
- HRTX 1.1M
- Earning Date
- CYRX 05-06-2025
- HRTX 05-06-2025
- Dividend Yield
- CYRX N/A
- HRTX N/A
- EPS Growth
- CYRX N/A
- HRTX N/A
- EPS
- CYRX N/A
- HRTX N/A
- Revenue
- CYRX $228,385,000.00
- HRTX $144,285,000.00
- Revenue This Year
- CYRX N/A
- HRTX $11.81
- Revenue Next Year
- CYRX $5.30
- HRTX $15.79
- P/E Ratio
- CYRX N/A
- HRTX N/A
- Revenue Growth
- CYRX N/A
- HRTX 13.57
- 52 Week Low
- CYRX $4.58
- HRTX $1.04
- 52 Week High
- CYRX $17.41
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- CYRX 46.04
- HRTX 39.27
- Support Level
- CYRX $5.34
- HRTX $1.65
- Resistance Level
- CYRX $5.97
- HRTX $2.00
- Average True Range (ATR)
- CYRX 0.66
- HRTX 0.14
- MACD
- CYRX 0.02
- HRTX -0.03
- Stochastic Oscillator
- CYRX 38.82
- HRTX 30.16
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.